Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2K Buy
3,478
+2,003
+136% +$8.45K ﹤0.01% 6941
2025
Q4
$6.79K Sell
1,475
-1,000
-40% -$5.15K ﹤0.01% 6985
2025
Q3
$11.4K Hold
2,475
﹤0.01% 6866
2025
Q2
$18.5K Sell
2,475
-260
-10% -$1.79K ﹤0.01% 6676
2025
Q1
$19.1K Buy
2,735
+1,499
+121% +$15.3K ﹤0.01% 6589
2024
Q4
$9.89K Buy
1,236
+1,000
+424% +$8.73K ﹤0.01% 6805
2024
Q3
$2.25K Buy
236
+235
+23,500% +$1.95K ﹤0.01% 7106
2024
Q2
$7 Buy
+1
New +$9 ﹤0.01% 7797

Other funds holding NYXH

Morgan Stanley's NYXH Position: Q1 2026 in Review

Morgan Stanley increased its Nyxoah (NYXH) stake by 136% in Q1 2026, buying an estimated $8.45K and bringing the position to 3,478 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6941.

Morgan Stanley first reported a position in NYXH in Q2 2024 and has held it in 8 quarters since. The position peaked at $19.1K in Q1 2025. 34 funds tracked by Wall St. Rank hold NYXH as of Q1 2026.

  • Morgan Stanley held 3,478 shares of Nyxoah worth $10.2K as of Q1 2026.
  • Morgan Stanley bought 2,003 Nyxoah shares in Q1 2026, an estimated $8.45K.
  • Nyxoah made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6941 holding.
  • Morgan Stanley first reported a position in Nyxoah in Q2 2024 and has held it in 8 quarters since.
  • Morgan Stanley's Nyxoah position peaked at $19.1K in Q1 2025.
  • 34 funds tracked by Wall St. Rank held Nyxoah as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.